Results from the proof of concept clinical trial Warfarin for symptomatic therapy in erythropoietic protoporphyria

被引：0
|
作者：
Doolan, B. [1 ]
Vu, M. [1 ]
Varigos, G. [1 ,2 ]
Hogan, C. [3 ]
Ross, G. [1 ]
Sood, S. [4 ]
Winship, I. [5 ]
机构：
[1] Royal Melbourne Hosp, Dept Dermatol, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Dept Haematol, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[5] Royal Melbourne Hosp, Dept Med Genet, Melbourne, Vic, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [1] Warfarin ineffective as symptomatic therapy for erythropoietic protoporphyria
    Doolan, Brent J.
    Vu, Mi
    Varigos, George A.
    Hogan, Chris
    Ross, Gayle
    Sood, Siddharth
    Winship, Ingrid
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (04) : E360 - E361
  • [2] Antioxidant Effect of Warfarin Therapy: A Possible Symptomatic Treatment for Erythropoietic Protoporphyria
    Winship, Ingrid
    Ross, Gayle
    Nicoll, Amanda
    Hogan, Chris
    Leong, Yoke
    Varigos, George
    [J]. ARCHIVES OF DERMATOLOGY, 2009, 145 (08) : 960 - 961
  • [3] Treatment of erythropoietic protoporphyria with the oral sorbent colestipol: A proof-of-concept clinical trial
    Tishler, Peter V.
    Rosner, Bernard
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) : 391 - 392
  • [4] The value of a trial of therapy - football as a 'proof-of-concept'
    Meadow, William
    Meadow, Xander
    Tanz, Robert R.
    Lagatta, Joanne
    Lantos, John
    [J]. ACTA PAEDIATRICA, 2011, 100 (02) : 167 - 169
  • [5] USING TWITTER TO HARVEST DATA FROM SCIENTIFIC CONFERENCES:A PROOF OF CONCEPT OF A NEW APPROACH TO RETRIEVE CLINICAL TRIAL RESULTS
    Prawitz, T.
    Kapetanakis, V
    Ishak, K. J.
    [J]. VALUE IN HEALTH, 2019, 22 : S766 - S766
  • [6] A proof of concept pilot trial of probiotics in symptomatic oral lichen planus (CABRIO)
    Marlina, Erni
    Goodman, Richard N.
    Mercadante, Valeria
    Shephard, Martina
    McMillan, Roddy
    Hodgson, Tim
    Leeson, Rachel
    Porter, Stephen
    Barber, Julie A.
    Fedele, Stefano
    Smith, Andrew M.
    [J]. ORAL DISEASES, 2022, 28 (08) : 2155 - 2167
  • [7] Clinical and biochemical improvement following low-dose intravenous iron therapy in a patient with erythropoietic protoporphyria
    Bentley, Douglas P.
    Meek, Elizabeth M.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (02) : 289 - 291
  • [8] Warfarin-aspirin symptomatic intracranial disease (WASID) trial: Final results
    Chimowitz, M
    Lynn, M
    Howlett-Smith, H
    Stern, B
    Hertzberg, VS
    Frankel, M
    Chaturvedi, S
    Kasner, S
    Benesch, C
    Sila, C
    Jovin, T
    Romano, J
    Levine, SR
    [J]. STROKE, 2004, 35 (01) : 235 - 235
  • [9] Interim Analyses from the Beacon Trial: A Phase 2, Randomized, Open-Label Trial of Bitopertin in Erythropoietic Protoporphyria
    Ross, Gayle
    Stewart, Peter
    Mensing, George
    Chin, Melanie
    Howell, Haley
    Mangus, Heidi
    Savage, William
    [J]. BLOOD, 2023, 142
  • [10] Dersimelagon, a melanocortin-1 receptor agonist, maintains efficacy regardless of seasons in subjects with erythropoietic protoporphyria: Results from a post hoc analysis of phase 2 clinical trial data
    Belongie, Kirstine
    Takahashi, Fumihiro
    Mukai, Sakiko
    Endou, Mai
    Desnick, Robert
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB156 - AB156
12345